doc. MUDr. Alexandr Poprach, Ph.D.

2024

• 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)

  LAKOMÝ Radek LOJOVÁ Martina SOUČKOVÁ Lenka HYNKOVÁ Ludmila POLÁCHOVÁ Kateřina VASINA Jiri DEMLOVÁ Regina POPRACH Alexandr ŠÁNA Jiří PROCHÁZKA Tomáš SMRČKA Martin FADRUS Pavel JANČÁLEK Radim SELINGEROVÁ Iveta BELANOVA Renata ŠLAMPA Pavel POSPÍŠIL Petr KAZDA Tomáš

  Článek v odborném periodiku

  BMC Cancer, rok: 2024, ročník: 24, vydání: 1, DOI

• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

  CHOUEIRI T. K. POWLES T. PELTOLA K. DE VELASCO G. BUROTTO M. SUAREZ C. GHATALIA P. IACOVELLI R. LAM E. T. VERZONI E. GUMUS M. STADLER W. M. KOLLMANNSBERGER C. MELICHAR B. VENUGOPAL B. GROSS-GOUPIL M. POPRACH Alexandr DE SANTIS M. SCHUTZ F. A. PARK S. H. NOSOV D. A. PORTA C. LEE J. L. GARCIA-DEL-MURO X. BISCALDI E. KOPP R Manneh OYA M. HE L. WANG A. PERINI R. F. VICKERY D. ALBIGES L. RINI B.

  Článek v odborném periodiku

  New England Journal of Medicine, rok: 2024, ročník: 391, vydání: 8, DOI

• Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic - data from Masaryk Memorial Cancer Institute registry in 2018-2022

  BÍLEK Ondřej SELINGEROVÁ Iveta KYSELA Michal JEDLIČKA Václav KAZDA Tomáš BERKOVCOVÁ J. TURČÁNI Pavel POPRACH Alexandr KISS Igor SVOBODA Marek ZDRAŽILOVÁ DUBSKÁ Lenka

  Článek v odborném periodiku

  Klinická onkologie, rok: 2024, ročník: 37, vydání: 6, DOI

• Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer

  BOŘILOVÁ Simona GRELL Peter SELINGEROVÁ Iveta GESCHEIDTOVÁ Lenka MLNAŘÍKOVÁ Marie BÍLEK Ondřej LAKOMÝ Radek POPRACH Alexandr PODHOREC Ján KISS Igor VYZULA Rostislav VAVRUŠÁKOVÁ Barbora NEVRLKA Jiří ZDRAŽILOVÁ DUBSKÁ Lenka

  Článek v odborném periodiku

  BMC Cancer, rok: 2024, ročník: 24, vydání: December, DOI

• Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study

  FIALA Ondrej MASSARI Francesco BASSO Umberto GIANNATEMPO Patrizia GRANDE Enrique BUTI Sebastiano MYINT Zin W UGO De Giorgi PICHLER Renate GRILLONE Francesco URUN Yuksel CALABRO Fabio BOURLON Maria T GALLI Luca KANESVARAN Ravindran ROVIELLO Giandomenico KUCHARZ Jakub RIZZO Mimma PARK Se Hoon CERBONE Linda SERONT Emmanuel MESSINA Carlo MOLINA-CERRILLO Javier SANTINI Daniele YANO Akihiro INCORVAIA Lorena CATALANO Martina PINTO Alvaro FORMISANO Luigi SOARES Andrey FACCHINI Gaetano FORNARINI Giuseppe POPRACH Alexandr REBUZZI Sara Elena NASSO Cecilia SPINELLI Gian Paolo MARTIN Angel STELLATO Marco TURAL Deniz AURILIO Gaetano EPSTEIN Ilana CARROZZA Francesco MONTEIRO Fernando Sabino Marques BENEDETTI Giovanni BUCHLER Tomas ORTEGA Cinzia ZAKOPOULOU Roubini BATTELLI Nicola PORTA Camillo BELLMUNT Joaquin GUPTA Shilpa SANTONI Matteo

  Článek v odborném periodiku

  Targeted Oncology, rok: 2024, DOI

• Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report

  POKRIVČÁK Tomáš NAVRÁTIL Jiří POPRACH Alexandr STANÍK Michal KISS Igor

  Článek v odborném periodiku

  CASE REPORTS IN ONCOLOGY, rok: 2024, ročník: 17, vydání: 1, DOI

• Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project

  RIZZO Alessandro MONTEIRO Fernando Sabino Marques URUN Yueksel MASSARI Francesco PARK Se Hoon BOURLON Maria T POPRACH Alexandr RIZZO Mimma TAKESHITA Hideki GIANNATEMPO Patrizia SOARES Andrey ROVIELLO Giandomenico MOLINA-CERRILLO Javier CARROZZA Francesco ABAHSSAIN Halima MESSINA Carlo KOPP Ray Manneh PICHLER Renate FORMISANO Luigi TURAL Deniz ATZORI Francesco CALABRO Fabio KANESVARAN Ravindran BUTI Sebastiano SANTONI Matteo

  Článek v odborném periodiku

  Targeted Oncology, rok: 2024, DOI

• Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy

  BÜCHLER Tomáš POPRACH Alexandr

  Článek v odborném periodiku

  Targeted Oncology, rok: 2024, ročník: 19, vydání: 2, DOI

• Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)

  SANTINI Daniele LI Haoran ROVIELLO Giandomenico PARK Se Hoon GRANDE Enrique KUCHARZ Jakub BASSO Umberto FIALA Ondrej MONTEIRO Fernando Sabino Marques POPRACH Alexandr BUTI Sebastiano MOLINA-CERRILLO Javier CATALANO Martina BUCHLER Tomas SERONT Emmanuel ANSARI Jawaher MYINT Zin W GHOSN Marwan CALABRO Fabio KOPP Ray Manneh BHUVA Dipen BOURLON Maria T ROBERTO Michela ALBERTO Di Civita Mattia MOLLICA Veronica MARCHETTI Andrea SOARES Andrey BATTELLI Nicola RICCI Marco KANESVARAN Ravindran BAMIAS Aristotelis PORTA Camillo MASSARI Francesco SANTONI Matteo

  Článek v odborném periodiku

  Targeted Oncology, rok: 2024, DOI

• Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations

  INCORVAIA Lorena MONTEIRO Fernando Sabino Marques MASSARI Francesco PARK Se Hoon ROVIELLO Giandomenico FIALA Ondrej MYINT Zin W KUCHARZ Jakub MOLINA-CERRILLO Javier SANTINI Daniele BUTTNER Thomas POPRACH Alexandr KOPECKY Jindrich ZEPPELLINI Annalisa PICHLER Martin BUCHLER Tomas PICHLER Renate FACCHINI Gaetano FAY Andre Poisl SOARES Andrey MANNEH Ray IEZZI Laura KURONYA Zsofia RUSSO Antonio BOURLON Maria T BHUVA Dipen ANSARI Jawaher KANESVARAN Ravindran GRANDE Enrique BUTI Sebastiano SANTONI Matteo

  Článek v odborném periodiku

  Cancer immunology, immunotherapy, rok: 2024, ročník: 73, vydání: 8, DOI